Springer Nature is making SARS-CoV-2 and COVID-19 research free View research | View latest news | Sign up for updates

Clinical differences between bone-seeking agents

  • 26 Accesses

  • 3 Citations

This is a preview of subscription content, log in to check access.

References

  1. Pauwels EKJ, Blom J, Camps JAJ, Hermans J, Rijke AM (1983) A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases. Eur J Nucl Med 8:118–122

  2. Schroth HJ, Hausinger F, Garth H, Oberhausen E (1984) Comparison of the kinetics of methylene-diphosphonate (MDP) and dicarboxypropane-diphosphonic acid (DPD), two radio-diagnostics for bone scintigraphy. Eur J Nucl Med 9:529–532

  3. Van Duzee BF, Schaefer JA, Ball JD, Chilton HM, Cowan RJ, Kuni C, Trow R, Watson NE (1984) Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP: Concise communication. J Nucl Med 25:166–169

  4. Vorne M, Vähätalo S, Lantto T (1983) A clinical comparison of Tc-99m DPD and two Tc-99m MDP agents. Eur J Nucl Med 8:395–397

Download references

Author information

Correspondence to J. W. Arndt M.D..

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Arndt, J.W., Pauwels, E.K.J., Camps, J.A.J. et al. Clinical differences between bone-seeking agents. Eur J Nucl Med 11, 330 (1985). https://doi.org/10.1007/BF00252349

Download citation

Keywords

  • Public Health
  • Nuclear Medicine
  • Clinical Difference